REVESTIVE
REVESTIVE
Approved
DIN Number
02445727
Drug Class
Human
Market Date
Oct 28, 2015
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02445727
AIG Number0157350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AX08 Teduglutide
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationSubcutaneous
AHFS Classification56:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TEDUGLUTIDEActive
Strength: 5 MG / VIAL
Monograph: TEDUGLUTIDE